secwatch.observer — SEC 8-K summary
======================================

Issuer:     MoonLake Immunotherapeutics (MLTX)
CIK:        0001821586
Form:       8-K
Filed at:   2026-07-14T21:31:54+00:00
Accession:  0001213900-26-078031
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

MoonLake Immunotherapeutics raises additional $30M from underwriters' overallotment exercise
--------------------------------------------------------------------------------

- Underwriters exercised in full their option to purchase 1,500,000 additional ordinary shares.
- Gross proceeds of $30.0 million from the sale of the option shares, before underwriting discounts.
- Closing of the option share issuance occurred on July 14, 2026.
- The option was part of a previously announced public offering of ordinary shares and pre-funded warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821586/000121390026078031/0001213900-26-078031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821586/000121390026078031/ea0298054-8k_moonlake.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-078031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer